SLC2A3 and breast cancer: With regard to the miR-195/497 cluster, it has been shown that miR-195 was downregulated in several cancers [38]–[40] and inhibited glucose uptake, proliferation, and cell cycle by targeting GLUT3 and CDK4 in BC [41], [42].